Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_38565 | 45 | 0.93 | Mlig455_054917 | Neo: - Age: - |
PCDH11X | Mlig455_054917 {REF} {Length: 4432} {Pfam: Cadherin domain [PF00028.19, score=225.5]; Cadherin-like [PF08266.14, score=38.0]} {Human: ENSG00000102290, PCDH11X, protocadherin 11 X-linked, [Score=237, Expect=4e-63]; ENSG00000099715, PCDH11Y, protocadherin 11 Y-linked, [Score=236, Expect=3e-63]} {Mouse: ENSMUSG00000034755, Pcdh11x, protocadherin 11 X-linked, [Score=238, Expect=6e-64]; ENSMUSG00000051375, Pcdh1, protocadherin 1, [Score=231, Expect=6e-62]; ENSMUSG00000044043, Pcdhb14, protocadherin beta 14, [Score=228, Expect=1e-61]; ENSMUSG00000045876, Pcdhb8, protocadherin beta 8, [Score=227, Expect=1e-61]} {Dmel: FBgn0284247, ds, dachsous, [Score=211, Expect=1e-54]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=168, Expect=9e-42]} {Smed: dd_Smed_v6_7973_0_2, dd_Smed_v6_7973_0_2, [Score=267, Expect=1e-73]} {RNA1310_85042} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -1.965 | 1.275 | 0.99957 | 1.00000 | |
RegionR2 | -0.169 | 1.275 | 0.87644 | 1.00000 | |
RegionR3 | 0.186 | 1.275 | 0.74761 | 1.00000 | |
RegionR4 | 2.621 | 1.275 | 0.14147 | 0.38483 | |
RegionR5 | 1.053 | 1.275 | 0.39692 | 0.75348 | |
RegionR6 | -0.176 | 1.275 | 0.84083 | 1.00000 | |
RegionR7 | -3.582 | 1.275 | 0.99979 | 1.00000 | |
RegionR8 | 2.031 | 1.275 | 0.32137 | 0.95546 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -1.007 | 1.275 | 1.00000 | 1.00000 | |
RegenerationR2 | 0.747 | 1.275 | 0.35997 | 0.78876 | |
RegenerationR3 | -2.278 | 1.275 | 0.08334 | 0.47198 | |
RegenerationR4 | -0.84 | 1.275 | 0.51051 | 0.87463 | |
RegenerationR5 | -2.634 | 1.275 | 0.03332 | 0.30423 | |
RegenerationR6 | -0.96 | 1.275 | 0.47275 | 0.78621 | |
RegenerationBL | -3.398 | 1.275 | 1.00000 | 1.00000 | |
RegenerationTP | -3.77 | 1.275 | 0.99956 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_38565 | 45 | 0.93 | Mlig455_054917 | Neo: - Age: - |
PCDH11X | 4 | - | - | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_054917 {REF} {Length: 4432} {Pfam: Cadherin domain [PF00028.19, score=225.5]; Cadherin-like [PF08266.14, score=38.0]} {Human: ENSG00000102290, PCDH11X, protocadherin 11 X-linked, [Score=237, Expect=4e-63]; ENSG00000099715, PCDH11Y, protocadherin 11 Y-linked, [Score=236, Expect=3e-63]} {Mouse: ENSMUSG00000034755, Pcdh11x, protocadherin 11 X-linked, [Score=238, Expect=6e-64]; ENSMUSG00000051375, Pcdh1, protocadherin 1, [Score=231, Expect=6e-62]; ENSMUSG00000044043, Pcdhb14, protocadherin beta 14, [Score=228, Expect=1e-61]; ENSMUSG00000045876, Pcdhb8, protocadherin beta 8, [Score=227, Expect=1e-61]} {Dmel: FBgn0284247, ds, dachsous, [Score=211, Expect=1e-54]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=168, Expect=9e-42]} {Smed: dd_Smed_v6_7973_0_2, dd_Smed_v6_7973_0_2, [Score=267, Expect=1e-73]} {RNA1310_85042} |
2. | MligTC455_24407 | 222 | 4.63 | Mlig455_044026 | Neo: - Age: Down-Up-Up Region-specific R2: 3.725 Region-enriched R2: 3.414/0.00001 |
3.541 | - | - | 0.870 | 0.883 | 0.960 | 0.828 | Mlig455_044026 {REF} {Length: 503} {RNA1509_54091} {RNA1310_68348.1} {RNA815_33570.1} | |
3. | MligTC455_17562 | 108 | 2.25 | Mlig455_022496 | Neo: - Age: - |
NECAB3 | 3.539 | - | - | 0.830 | 0.868 | 0.958 | 0.883 | Mlig455_022496 {REF} {Length: 1499} {Pfam: EF hand [PF00036.34, score=34.0]; EF-hand domain [PF13405.8, score=33.4]; EF-hand domain pair [PF13833.8, score=29.2]; EF-hand domain pair [PF13499.8, score=28.3]; Antibiotic biosynthesis monooxygenase [PF03992.18, score=22.0]; EF hand [PF13202.8, score=21.3]} {Human: ENSG00000125967, NECAB3, N-terminal EF-hand calcium binding protein 3, [RH, Score=189, Expect=7e-57]; ENSG00000123119, NECAB1, N-terminal EF-hand calcium binding protein 1, [RH, Score=186, Expect=1e-55]} {Mouse: ENSMUSG00000040536, Necab1, N-terminal EF-hand calcium binding protein 1, [RH, Score=191, Expect=7e-58]; ENSMUSG00000027489, Necab3, N-terminal EF-hand calcium binding protein 3, [RH, Score=191, Expect=9e-58]} {RNA1509_46831} {RNA1310_24461} {RNA815_25216} |
4. | MligTC455_43210 | 1513 | 31.51 | Mlig455_059969 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.253 Region-specific R2: 4.268 Region-enriched R2: 4.051/0.00000 |
3.403 | - | - | 0.706 | 0.860 | 0.954 | 0.883 | Mlig455_059969 {REF} {Length: 1263} {Pfam: Pancreatic hormone peptide [PF00159.20, score=46.6]} {Smed: dd_Smed_v6_16946_0_1, dd_Smed_v6_16946_0_1, [Score=41.6, Expect=1e-05]} {RNA1509_21159, RNA1509_26888, RNA1509_32920} {RNA1310_28339, RNA1509_21159, RNA1509_26888, RNA1509_32920} {RNA1509_21159, RNA1509_26888, RNA1509_32920, RNA815_20007.1} | |
5. | MligTC455_44861 | 2493 | 51.93 | Mlig455_012204, Mlig455_069065 | Neo: - Age: - Region-specific R2: 2.926 Region-enriched R2: 2.403/0.00000 Regeneration-downregulated BL: -1.850 Regeneration-depleted BL: -1.850 |
QPCT | 3.4 | - | - | 0.765 | 0.815 | 0.972 | 0.848 | Mlig455_012204 {REF} {Length: 1746} {Pfam: Peptidase family M28 [PF04389.19, score=139.1]} {Human: ENSG00000115828, QPCT, glutaminyl-peptide cyclotransferase, [RH, Score=186, Expect=7e-56]; ENSG00000011478, QPCTL, glutaminyl-peptide cyclotransferase like, [RH, Score=181, Expect=2e-53]} {Mouse: ENSMUSG00000030407, Qpctl, glutaminyl-peptide cyclotransferase-like, [RH, Score=184, Expect=6e-55]; ENSMUSG00000024084, Qpct, glutaminyl-peptide cyclotransferase (glutaminyl cyclase), [RH, Score=184, Expect=2e-55]} {Dmel: FBgn0036999, isoQC, iso Glutaminyl cyclase, [RH, Score=208, Expect=8e-65]} {Celegans: WBGene00010418, H27A22.1, [Score=183, Expect=2e-55]} {Smed: dd_Smed_v6_4861_0_2, dd_Smed_v6_4861_0_2, [Score=162, Expect=3e-47]} {RNA1509_15042} {RNA1310_21925} {RNA815_8635.2} Mlig455_069065 {REF} {Length: 1718} {Pfam: Peptidase family M28 [PF04389.19, score=83.4]} {Human: ENSG00000115828, QPCT, glutaminyl-peptide cyclotransferase, [Score=133, Expect=1e-36]; ENSG00000011478, QPCTL, glutaminyl-peptide cyclotransferase like, [Score=128, Expect=1e-34]} {Mouse: ENSMUSG00000024084, Qpct, glutaminyl-peptide cyclotransferase (glutaminyl cyclase), [Score=138, Expect=1e-38]; ENSMUSG00000030407, Qpctl, glutaminyl-peptide cyclotransferase-like, [Score=135, Expect=2e-37]} {Dmel: FBgn0036999, isoQC, iso Glutaminyl cyclase, [Score=157, Expect=3e-46]} {Celegans: WBGene00010418, H27A22.1, [Score=148, Expect=9e-43]} {Smed: dd_Smed_v6_4861_0_1, dd_Smed_v6_4861_0_1, [Score=119, Expect=8e-32]} {RNA1509_15042} {RNA1310_21925} {RNA815_8635.2} |
6. | MligTC455_17701 | 1279 | 26.65 | Mlig455_051483 | Neo: - Age: Down-Up-Up Region-specific R2: 5.592 Region-enriched R2: 6.602/0.00000 |
3.33 | - | - | 0.731 | 0.832 | 0.783 | 0.984 | Mlig455_051483 {REF} {Length: 1833} {RNA1509_14131} {RNA1310_69964.2, RNA1509_14131} {RNA1509_14131, RNA815_35453.1} | |
7. | MligTC455_51557 | 57 | 1.19 | Mlig455_038195 | Neo: - Age: Down-Up-Up |
ISL1 | 2.799 | - | - | 0.905 | 0.920 | 0.974 | - | Mlig455_038195 {REF} {Length: 2149} {Pfam: LIM domain [PF00412.24, score=91.4]; Homeodomain [PF00046.31, score=55.3]; Homeobox KN domain [PF05920.13, score=23.4]} {Human: ENSG00000016082, ISL1, ISL LIM homeobox 1, [Score=180, Expect=9e-52]; ENSG00000159556, ISL2, ISL LIM homeobox 2, [Score=173, Expect=3e-49]} {Mouse: ENSMUSG00000042258, Isl1, ISL1 transcription factor, LIM/homeodomain, [Score=180, Expect=6e-52]; ENSMUSG00000032318, Isl2, insulin related protein 2 (islet 2), [Score=175, Expect=4e-50]} {Dmel: FBgn0003896, tup, tailup, [Score=151, Expect=3e-40]} {Celegans: WBGene00002989, lim-7, CeLIM-7; LIM domain family, [Score=142, Expect=2e-37]} {Smed: dd_Smed_v6_8820_0_1, dd_Smed_v6_8820_0_1, [Score=303, Expect=1e-97]} {RNA1310_54855} {RNA815_46288} |
8. | MligTC455_17586 | 579 | 12.07 | Mlig455_029070 | Neo: - Age: - Region-specific R2: 3.959 Region-enriched R2: 2.423/0.00859 Regeneration-downregulated R6: -3.050 Regeneration-depleted R6: -3.050 |
2.739 | - | - | - | 0.909 | 0.968 | 0.862 | Mlig455_029070 {REF} {Length: 859} {RNA1509_53221, RNA1509_56226} {RNA1310_52775.1, RNA1509_53221, RNA1509_56226} {RNA1509_53221, RNA1509_56226, RNA815_35656} | |
9. | MligTC455_45351 | 241 | 5.02 | Mlig455_031191 | Neo: - Age: Down-Up-Down Region-enriched R2: 4.622/0.00310 |
2.734 | - | - | - | 0.912 | 0.971 | 0.851 | Mlig455_031191 {REF} {Length: 2855} {Pfam: Srg family chemoreceptor [PF02118.23, score=28.1]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=26.4]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=26.4]} {Celegans: WBGene00019019, frpr-10, FMRFamide Peptide Receptor family, [Score=49.3, Expect=2e-06]} {Smed: dd_Smed_v6_7534_0_1, dd_Smed_v6_7534_0_1, [Score=54.7, Expect=4e-08]} {RNA1509_20184} {RNA1310_32455} {RNA815_38062} | |
10. | MligTC455_18599 | 119 | 2.47 | Mlig455_031197 | Neo: - Age: Down-Up-Up Region-enriched R2: 4.553/0.00808 |
2.73 | - | - | - | 0.840 | 0.952 | 0.938 | Mlig455_031197 {REF} {Length: 1284} {RNA1310_35452} | |
11. | MligTC455_46430 | 62 | 1.29 | Mlig455_057117, Mlig455_069301 | Neo: - Age: - |
GUCY2F | 2.724 | - | - | 0.834 | 0.929 | 0.961 | - | Mlig455_057117 {REF} {Length: 2651} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=196.0]; Nitrate and nitrite sensing [PF08376.12, score=82.5]; Heme NO binding associated [PF07701.16, score=28.2]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=247, Expect=9e-70]; ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=242, Expect=3e-68]; ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=238, Expect=5e-67]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [Score=246, Expect=7e-70]; ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=242, Expect=2e-68]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=241, Expect=7e-68]; ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=239, Expect=3e-67]} {Dmel: FBgn0053958, CG33958, [Score=266, Expect=4e-79]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=235, Expect=3e-66]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [Score=238, Expect=4e-67]} {RNA1509_38781} {RNA1310_35456} {RNA815_22108} Mlig455_069301 {REF} {Length: 2370} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=178.1]; Nitrate and nitrite sensing [PF08376.12, score=82.3]; Heme NO binding associated [PF07701.16, score=28.0]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=232, Expect=2e-64]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [Score=232, Expect=1e-64]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=225, Expect=5e-62]} {Dmel: FBgn0053958, CG33958, [Score=250, Expect=5e-73]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=223, Expect=1e-61]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [Score=221, Expect=4e-61]} {RNA1509_38781} {RNA1310_35456} {RNA815_24181} |
12. | MligTC455_09510 | 314 | 6.55 | Mlig455_001134, Mlig455_042048 | Neo: - Age: - Region-specific R2: 5.291 Region-enriched R2: 5.151/0.00029 |
2.722 | - | - | 0.809 | 0.921 | 0.992 | - | Mlig455_001134 {REF} {Length: 485} {Pfam: Fingers domain of DNA polymerase lambda [PF10391.11, score=26.9]} {RNA1310_8738.1} {RNA815_21682.1} Mlig455_042048 {REF} {Length: 1550} {Pfam: Fingers domain of DNA polymerase lambda [PF10391.11, score=32.1]} {Dmel: FBgn0036416, CG7924, [RH, Score=61.2, Expect=1e-10]} {RNA1509_51261} {RNA1310_8738.1} {RNA815_21682.1} |
|
13. | MligTC455_24985 | 43 | 0.89 | Mlig455_005348, Mlig455_005464 | Neo: - Age: - |
ADRA1A, HTR1A | 2.72 | - | - | 0.881 | 0.889 | 0.950 | - | Mlig455_005348 {REF} {Length: 1845} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=222.9]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=41.4]} {Human: ENSG00000120907, ADRA1A, adrenoceptor alpha 1A, [Score=186, Expect=3e-54]; ENSG00000178394, HTR1A, 5-hydroxytryptamine receptor 1A, [Score=184, Expect=1e-53]; ENSG00000170214, ADRA1B, adrenoceptor alpha 1B, [Score=179, Expect=1e-50]} {Mouse: ENSMUSG00000045875, Adra1a, adrenergic receptor, alpha 1a, [Score=181, Expect=1e-52]; ENSMUSG00000021721, Htr1a, 5-hydroxytryptamine (serotonin) receptor 1A, [Score=179, Expect=5e-52]; ENSMUSG00000050541, Adra1b, adrenergic receptor, alpha 1b, [Score=179, Expect=7e-51]} {Dmel: FBgn0011582, Dop1R1, Dopamine 1-like receptor 1, [Score=162, Expect=3e-45]} {Celegans: WBGene00004777, ser-2, Tyramine receptor Ser-2, [Score=181, Expect=7e-53]} {Smed: dd_Smed_v6_33950_0_1, dd_Smed_v6_33950_0_1, [Score=254, Expect=1e-80]} {RNA1310_56787} Mlig455_005464 {REF} {Length: 1742} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=223.9]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=43.6]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=21.7]; Presenilin [PF01080.19, score=17.5]} {Human: ENSG00000178394, HTR1A, 5-hydroxytryptamine receptor 1A, [Score=194, Expect=7e-57]; ENSG00000150594, ADRA2A, adrenoceptor alpha 2A, [Score=191, Expect=4e-55]} {Mouse: ENSMUSG00000058620, Adra2b, adrenergic receptor, alpha 2b, [RH, Score=184, Expect=5e-53]} {Dmel: FBgn0053517, Dop2R, Dopamine 2-like receptor, [Score=172, Expect=1e-46]} {Celegans: WBGene00017157, tyra-2, Tyramine receptor tyra-2, [RH, Score=216, Expect=3e-65]} {Smed: dd_Smed_v6_33950_0_1, dd_Smed_v6_33950_0_1, [RH, Score=329, Expect=1e-108]} {RNA1310_56787} |
14. | MligTC455_40444 | 2996 | 62.42 | Mlig455_039527, Mlig455_051318 | Neo: - Age: Down-Up-Down |
2.72 | - | - | - | 0.878 | 0.878 | 0.964 | Mlig455_039527 {REF} {Length: 710} {RNA1509_7655} {RNA1310_63393} {RNA815_30324} Mlig455_051318 {REF} {Length: 721} {RNA1509_7655} {RNA1310_63393, RNA1509_7655} {RNA1509_7655, RNA815_30324} |
|
15. | MligTC455_13421 | 86 | 1.79 | Mlig455_036504, Mlig455_069144 | Neo: - Age: - |
SYT17 | 2.716 | - | - | 0.947 | 0.782 | 0.987 | - | Mlig455_036504 {REF} {Length: 2390} {Pfam: C2 domain [PF00168.32, score=84.3]} {Human: ENSG00000103528, SYT17, synaptotagmin 17, [Score=137, Expect=5e-35]} {Mouse: ENSMUSG00000058420, Syt17, synaptotagmin XVII, [Score=137, Expect=6e-35]} {Dmel: FBgn0028400, Syt4, Synaptotagmin 4, [Score=101, Expect=1e-22]} {Celegans: WBGene00004922, snt-2, Synaptotagmin 2, [Score=105, Expect=2e-24]} {Smed: dd_Smed_v6_19213_0_1, dd_Smed_v6_19213_0_1, [RH, Score=124, Expect=2e-30]} {RNA1310_17303} {RNA815_33031} Mlig455_069144 {REF} {Length: 1355} {Pfam: C2 domain [PF00168.32, score=84.3]} {Human: ENSG00000103528, SYT17, synaptotagmin 17, [Score=137, Expect=5e-35]} {Mouse: ENSMUSG00000058420, Syt17, synaptotagmin XVII, [Score=137, Expect=6e-35]} {Dmel: FBgn0028400, Syt4, Synaptotagmin 4, [Score=101, Expect=1e-22]} {Celegans: WBGene00004922, snt-2, Synaptotagmin 2, [Score=105, Expect=2e-24]} {Smed: dd_Smed_v6_19213_0_1, dd_Smed_v6_19213_0_1, [RH, Score=124, Expect=2e-30]} {RNA1310_17303} {RNA815_33031} |
16. | MligTC455_27216 | 56 | 1.18 | Mlig455_022418 | Neo: - |
TRPM3 | 2.698 | - | - | 0.855 | 0.877 | 0.966 | - | Mlig455_022418 {REF} {Length: 4794} {Pfam: SLOG in TRPM [PF18139.3, score=136.8]; Ion transport protein [PF00520.33, score=41.0]; SLOG in TRPM, prokaryote [PF18171.3, score=34.2]} {Human: ENSG00000083067, TRPM3, transient receptor potential cation channel subfamily M member 3, [Score=317, Expect=2e-88]; ENSG00000119121, TRPM6, transient receptor potential cation channel subfamily M member 6, [Score=316, Expect=4e-88]} {Mouse: ENSMUSG00000052387, Trpm3, transient receptor potential cation channel, subfamily M, member 3, [Score=319, Expect=4e-90]} {Dmel: FBgn0265194, Trpm, Transient receptor potential cation channel, subfamily M, [Score=309, Expect=7e-88]} {Celegans: WBGene00001796, gtl-2, Gon-Two Like (TRP subfamily), [Score=255, Expect=4e-69]} {Smed: dd_Smed_v6_9288_0_1, dd_Smed_v6_9288_0_1, [Score=418, Expect=3e-126]} {RNA1509_17593} {RNA1310_1651, RNA1509_17593} {RNA1509_17593, RNA815_2281} |
17. | MligTC455_17561 | 189 | 3.94 | Mlig455_020268 | Neo: - Age: - Region-enriched R2: 4.198/0.00004 |
NECAB3 | 2.678 | - | - | - | 0.890 | 0.826 | 0.962 | Mlig455_020268 {REF} {Length: 1518} {Pfam: EF hand [PF00036.34, score=34.0]; EF-hand domain [PF13405.8, score=33.4]; EF-hand domain pair [PF13833.8, score=29.2]; EF-hand domain pair [PF13499.8, score=28.3]; Antibiotic biosynthesis monooxygenase [PF03992.18, score=22.0]; EF hand [PF13202.8, score=21.3]} {Human: ENSG00000125967, NECAB3, N-terminal EF-hand calcium binding protein 3, [RH, Score=189, Expect=7e-57]; ENSG00000123119, NECAB1, N-terminal EF-hand calcium binding protein 1, [RH, Score=186, Expect=1e-55]} {Mouse: ENSMUSG00000040536, Necab1, N-terminal EF-hand calcium binding protein 1, [RH, Score=192, Expect=6e-58]; ENSMUSG00000027489, Necab3, N-terminal EF-hand calcium binding protein 3, [RH, Score=191, Expect=9e-58]} {RNA1509_46831} {RNA1310_24461, RNA1509_46831} {RNA1509_46831, RNA815_25216} |
18. | MligTC455_51386 | 763 | 15.89 | Mlig455_041336, Mlig455_056222 | Neo: - Age: - Region-enriched R2: 3.643/0.00016 |
HPGDS | 2.674 | - | - | 0.824 | - | 0.989 | 0.861 | Mlig455_041336 {REF} {Length: 1363} {Pfam: Glutathione S-transferase, C-terminal domain [PF14497.8, score=46.9]; Glutathione S-transferase, N-terminal domain [PF02798.22, score=34.8]; Glutathione S-transferase, N-terminal domain [PF13409.8, score=23.3]; Glutathione S-transferase, N-terminal domain [PF13417.8, score=22.4]} {Human: ENSG00000163106, HPGDS, hematopoietic prostaglandin D synthase, [Score=74.7, Expect=2e-15]} {Mouse: ENSMUSG00000029919, Hpgds, hematopoietic prostaglandin D synthase, [Score=82.4, Expect=2e-18]} {Celegans: WBGene00001756, gst-8, Probable glutathione S-transferase 8, [Score=92.8, Expect=2e-22]} {Smed: dd_Smed_v6_1206_0_1, dd_Smed_v6_1206_0_1, [Score=79.0, Expect=2e-17]} {RNA1509_56224} {RNA1310_31890.2} {RNA815_14778} Mlig455_056222 {REF} {Length: 1343} {Pfam: Glutathione S-transferase, C-terminal domain [PF14497.8, score=62.1]; Glutathione S-transferase, N-terminal domain [PF02798.22, score=34.8]; Glutathione S-transferase, C-terminal domain [PF00043.27, score=31.1]; Glutathione S-transferase, N-terminal domain [PF13409.8, score=23.4]; Glutathione S-transferase, N-terminal domain [PF13417.8, score=22.5]; Glutathione S-transferase, C-terminal domain [PF13410.8, score=21.8]} {Human: ENSG00000163106, HPGDS, hematopoietic prostaglandin D synthase, [Score=78.2, Expect=8e-17]} {Mouse: ENSMUSG00000029919, Hpgds, hematopoietic prostaglandin D synthase, [Score=85.5, Expect=1e-19]} {Celegans: WBGene00001750, gst-2, Glutathione S-transferase 2, [RH, Score=96.7, Expect=3e-24]} {Smed: dd_Smed_v6_1206_0_1, dd_Smed_v6_1206_0_1, [Score=84.3, Expect=2e-19]} {RNA1509_56224} {RNA1310_31890.2} {RNA815_14778} |
19. | MligTC455_29725 | 72 | 1.49 | Mlig455_014390 | Neo: - Age: - Region-enriched R2: 7.905/0.00012 |
OTOP2 | 2.673 | - | - | 0.917 | 0.796 | 0.960 | - | Mlig455_014390 {REF} {Length: 2547} {Pfam: Otopetrin [PF03189.15, score=220.6]} {Human: ENSG00000183034, OTOP2, otopetrin 2, [Score=52.0, Expect=3e-06]; ENSG00000163982, OTOP1, otopetrin 1, [Score=49.7, Expect=1e-05]} {Mouse: ENSMUSG00000051596, Otop1, otopetrin 1, [Score=53.5, Expect=7e-07]; ENSMUSG00000050201, Otop2, otopetrin 2, [Score=51.6, Expect=3e-06]} {Dmel: FBgn0259150, CG42265, [Score=177, Expect=3e-46]} {Celegans: WBGene00017034, otpl-2, OToPetrin-Like, [Score=101, Expect=2e-22]} {Smed: dd_Smed_v6_13612_0_3, dd_Smed_v6_13612_0_3, [Score=276, Expect=7e-84]} {RNA1310_55206} {RNA815_48323} |
20. | MligTC455_27678 | 355 | 7.4 | Mlig455_070610 | Neo: - Age: - Region-specific R2: 4.724 Region-enriched R2: 3.766/0.00062 |
2.665 | - | - | - | 0.782 | 0.973 | 0.910 | Mlig455_070610 {REF} {Length: 725} {RNA1509_17468, RNA1509_34237} {RNA1310_59474, RNA1509_17468, RNA1509_34237} {RNA1509_17468, RNA1509_34237, RNA815_28024} | |
21. | MligTC455_53720 | 144 | 2.99 | Mlig455_028516 | Neo: - Age: - Region-enriched R2: 4.205/0.01762 |
CTBP2 | 2.665 | - | - | 0.790 | 0.916 | 0.959 | - | Mlig455_028516 {REF} {Length: 3357} {TRANSSPLICED} {Pfam: D-isomer specific 2-hydroxyacid dehydrogenase, NAD binding domain [PF02826.21, score=112.7]; D-isomer specific 2-hydroxyacid dehydrogenase, catalytic domain [PF00389.32, score=67.2]; THAP domain [PF05485.14, score=38.8]; NAD binding domain of 6-phosphogluconate dehydrogenase [PF03446.17, score=22.2]} {Human: ENSG00000175029, CTBP2, C-terminal binding protein 2, [Score=370, Expect=3e-115]; ENSG00000159692, CTBP1, C-terminal binding protein 1, [Score=360, Expect=1e-117]} {Mouse: ENSMUSG00000030970, Ctbp2, C-terminal binding protein 2, [Score=372, Expect=5e-116]; ENSMUSG00000037373, Ctbp1, C-terminal binding protein 1, [Score=362, Expect=8e-119]} {Dmel: FBgn0020496, CtBP, C-terminal Binding Protein, [Score=354, Expect=1e-116]} {Celegans: WBGene00006424, ctbp-1, C-terminal-binding protein 1, [Score=475, Expect=8e-159]} {Smed: dd_Smed_v6_1063_0_1, dd_Smed_v6_1063_0_1, [Score=354, Expect=3e-115]} {RNA1310_37204} {RNA815_48484} |
22. | MligTC455_44956 | 144 | 2.99 | Mlig455_061510 | Neo: - Age: - |
2.659 | - | - | 0.783 | 0.887 | 0.989 | - | Mlig455_061510 {REF} {Length: 493} {Pfam: Pancreatic hormone peptide [PF00159.20, score=31.3]} {Smed: dd_Smed_v6_6375_0_1, dd_Smed_v6_6375_0_1, [RH, Score=47.8, Expect=9e-09]} {RNA1509_17163} {RNA1310_66833.1} {RNA815_41767} | |
23. | MligTC455_47420 | 218 | 4.54 | Mlig455_017159, Mlig455_048110 | Neo: - Age: - Region-specific R2: 6.469 Region-enriched R2: 5.851/0.00135 |
2.659 | - | - | 0.781 | 0.900 | 0.978 | - | Mlig455_017159 {REF} {Length: 1062} {RNA1509_35349} {RNA1310_81586} Mlig455_048110 {REF} {Length: 527} {RNA1310_81586} |
|
24. | MligTC455_43715 | 48 | 0.99 | Mlig455_034191 | Neo: - Age: Down-Up-Down Region-enriched R2: 7.969/0.00817 |
2.65 | - | - | 0.796 | 0.883 | 0.971 | - | Mlig455_034191 {REF} {Length: 895} {Pfam: WSC domain [PF01822.21, score=39.9]; PAN domain [PF14295.8, score=21.0]; PAN domain [PF00024.28, score=19.9]} {RNA1310_46313} {RNA815_23250} | |
25. | MligTC455_46452 | 134 | 2.79 | Mlig455_048151 | Neo: - Age: - Region-specific R2: 6.389 Region-enriched R2: 7.075/0.00014 Regeneration-downregulated R2: -3.162 Regeneration-depleted R2: -3.162 |
2.65 | - | - | 0.779 | 0.878 | 0.993 | - | Mlig455_048151 {REF} {Length: 618} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=25.7]} {RNA1310_62963} {RNA815_31352} | |
26. | MligTC455_35044 | 248 | 5.17 | Mlig455_037400 | Neo: - Age: Up-Down-Up Region-enriched R2: 3.538/0.00372 |
2.648 | - | - | 0.764 | 0.898 | 0.986 | - | Mlig455_037400 {REF} {Length: 2022} {RNA1509_41763} {RNA1310_23070.1, RNA1509_41763} {RNA1509_41763, RNA815_9632} | |
27. | MligTC455_30463 | 95 | 1.98 | Mlig455_000250, Mlig455_058521, Mlig455_058532 | Neo: - Age: - |
2.647 | - | - | 0.750 | 0.907 | 0.990 | - | Mlig455_000250 {REF} {Length: 1994} {Pfam: Transcription factor IIA, alpha/beta subunit [PF03153.15, score=19.7]} {RNA1310_59451} {RNA815_40085} Mlig455_058521 {REF} {Length: 1237} {RNA1310_56656} {RNA815_40085} Mlig455_058532 {REF} {Length: 1973} {Pfam: Transcription factor IIA, alpha/beta subunit [PF03153.15, score=19.5]} {RNA1310_59451} {RNA815_40085} |
|
28. | MligTC455_14598 | 52 | 1.07 | Mlig455_058970 | Neo: - Age: - |
2.644 | - | - | 0.880 | 0.810 | 0.954 | - | Mlig455_058970 {REF} {Length: 1038} {RNA1310_39570} {RNA815_52309} | |
29. | MligTC455_33277 | 1450 | 30.2 | Mlig455_031182 | Neo: - Age: - Region-specific R2: 3.361 Region-enriched R2: 2.732/0.00000 |
TRO | 2.639 | - | - | - | 0.901 | 0.982 | 0.756 | Mlig455_031182 {REF} {Length: 1600} {Human: ENSG00000067445, TRO, trophinin, [Score=52.8, Expect=3e-08]} {Smed: dd_Smed_v6_1015_0_1, dd_Smed_v6_1015_0_1, [RH, Score=43.9, Expect=3e-06]} {RNA1509_34972} {RNA1310_37320, RNA1509_34972} {RNA1509_34972, RNA815_25574} |
30. | MligTC455_40687 | 28 | 0.58 | Mlig455_040563, Mlig455_062078 | Neo: - Age: - |
PDE1C | 2.638 | - | - | 0.718 | 0.925 | 0.995 | - | Mlig455_040563 {REF} {Length: 1798} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=268.1]; 3'5'-cyclic nucleotide phosphodiesterase N-terminal [PF08499.14, score=29.0]} {Human: ENSG00000154678, PDE1C, phosphodiesterase 1C, [Score=362, Expect=2e-117]; ENSG00000115252, PDE1A, phosphodiesterase 1A, [Score=358, Expect=2e-117]} {Mouse: ENSMUSG00000004347, Pde1c, phosphodiesterase 1C, [Score=362, Expect=5e-118]; ENSMUSG00000059173, Pde1a, phosphodiesterase 1A, calmodulin-dependent, [Score=362, Expect=7e-120]} {Dmel: FBgn0264815, Pde1c, Phosphodiesterase 1c, [Score=346, Expect=4e-108]} {Celegans: WBGene00011433, pde-1, Probable 3',5'-cyclic phosphodiesterase pde-1, [Score=347, Expect=3e-113]} {Smed: dd_Smed_v6_21546_0_1, dd_Smed_v6_21546_0_1, [Score=396, Expect=7e-133]} {RNA1310_80402} Mlig455_062078 {REF} {Length: 1807} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=268.6]; 3'5'-cyclic nucleotide phosphodiesterase N-terminal [PF08499.14, score=29.1]} {Human: ENSG00000154678, PDE1C, phosphodiesterase 1C, [Score=356, Expect=3e-115]; ENSG00000115252, PDE1A, phosphodiesterase 1A, [Score=355, Expect=5e-116]} {Mouse: ENSMUSG00000059173, Pde1a, phosphodiesterase 1A, calmodulin-dependent, [Score=359, Expect=1e-118]; ENSMUSG00000004347, Pde1c, phosphodiesterase 1C, [Score=356, Expect=8e-116]} {Dmel: FBgn0264815, Pde1c, Phosphodiesterase 1c, [Score=347, Expect=2e-108]} {Celegans: WBGene00011433, pde-1, Probable 3',5'-cyclic phosphodiesterase pde-1, [Score=347, Expect=3e-113]} {Smed: dd_Smed_v6_26758_0_1, dd_Smed_v6_26758_0_1, [Score=394, Expect=3e-132]} {RNA1509_46211} {RNA1310_80402} {RNA815_55704} |
31. | MligTC455_41724 | 23 | 0.49 | Mlig455_001647 | Neo: - |
2.635 | - | - | 0.739 | 0.923 | 0.973 | - | Mlig455_001647 {REF} {Length: 1808} {RNA1310_22665} {RNA815_13308} | |
32. | MligTC455_12126 | 26 | 0.55 | Mlig455_040946 | Neo: - Age: - |
2.633 | - | - | 0.768 | 0.898 | 0.967 | - | Mlig455_040946 {REF} {Length: 1894} {RNA1310_146540} {RNA815_59956} | |
33. | MligTC455_43643 | 2324 | 48.41 | Mlig455_065102 | Neo: - Age: - Region-specific R2: 2.496 Region-enriched R2: 1.834/0.00001 Regeneration-downregulated R6: -1.642 Regeneration-depleted R6: -1.642 |
2.633 | - | - | - | 0.840 | 0.979 | 0.814 | Mlig455_065102 {REF} {Length: 850} {RNA1509_16353, RNA1509_24268} {RNA1310_47277.1, RNA1509_24268} {RNA1509_24268, RNA815_19145.2} | |
34. | MligTC455_17178 | 54 | 1.12 | Mlig455_067758 | Neo: - Age: - Region-enriched R2: 7.471/0.00007 |
2.632 | - | - | 0.746 | 0.902 | 0.984 | - | Mlig455_067758 {REF} {Length: 2301} {RNA1509_44702} {RNA1310_14743} {RNA815_20669.1} | |
35. | MligTC455_47780 | 214 | 4.46 | Mlig455_018842, Mlig455_018853 | Neo: - Age: - |
2.632 | - | - | 0.758 | 0.894 | 0.980 | - | Mlig455_018842 {REF} {Length: 500} {RNA1509_48336} {RNA1310_73351} {RNA815_41082} Mlig455_018853 {REF} {Length: 593} {RNA1509_48336} {RNA1310_73351, RNA1509_48336} {RNA1509_48336, RNA815_41082} |
|
36. | MligTC455_49919 | 745 | 15.52 | Mlig455_017182, Mlig455_048150 | Neo: - Age: - Region-specific R2: 7.180 Region-enriched R2: 7.978/0.00000 Regeneration-downregulated R2: -4.649 Regeneration-depleted R2: -4.649 |
2.632 | - | - | 0.744 | 0.900 | 0.988 | - | Mlig455_017182 {REF} {Length: 576} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.2]} {RNA1509_35830, RNA1509_49816, RNA1509_53987} {RNA1310_60849, RNA1509_35830, RNA1509_49816, RNA1509_53987} {RNA1509_35830, RNA1509_49816, RNA1509_53987, RNA815_31347} Mlig455_048150 {REF} {Length: 574} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.2]} {RNA1509_35830} {RNA1310_60849} {RNA815_31347} |
|
37. | MligTC455_48713 | 380 | 7.92 | Mlig455_009259, Mlig455_009268 | Neo: - Age: Down-Up-Down Region-specific R2: 6.962 Region-enriched R2: 4.845/0.00046 |
2.631 | - | - | 0.720 | 0.937 | 0.974 | - | Mlig455_009259 {REF} {Length: 654} {RNA1509_35038} {RNA1310_72135} {RNA815_37404} Mlig455_009268 {REF} {Length: 546} {RNA1509_35038} {RNA1310_72135, RNA1509_35038} {RNA1509_35038, RNA815_37404} |
|
38. | MligTC455_43642 | 2199 | 45.81 | Mlig455_018475 | Neo: - Age: Down-Up-Up Region-specific R2: 2.701 Region-enriched R2: 2.110/0.00000 |
2.626 | - | - | - | 0.837 | 0.975 | 0.814 | Mlig455_018475 {REF} {Length: 949} {RNA1509_30521} {RNA1310_47277.3, RNA1509_30521} {RNA1509_30521, RNA815_19145.1} | |
39. | MligTC455_48656 | 24 | 0.5 | Mlig455_039647 | Neo: - Age: - |
2.626 | - | - | 0.718 | 0.935 | 0.973 | - | Mlig455_039647 {REF} {Length: 1715} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=42.7]} {RNA1310_48037} {RNA815_27969} | |
40. | MligTC455_51334 | 326 | 6.78 | Mlig455_011442, Mlig455_061180 | Neo: - |
2.626 | - | - | 0.751 | 0.903 | 0.972 | - | Mlig455_011442 {REF} {Length: 742} {RNA1310_57576.1} {RNA815_29867} Mlig455_061180 {REF} {Length: 769} {RNA1310_57576.1} {RNA815_29867} |
|
41. | MligTC455_10018 | 16 | 0.32 | Mlig455_034726, Mlig455_067577 | Neo: - Age: - |
GUCY2D, GUCY2F | 2.62 | - | - | 0.744 | 0.893 | 0.983 | - | Mlig455_034726 {REF} {Length: 4473} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=210.0]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=104.6]; Protein kinase domain [PF00069.27, score=72.8]; Receptor family ligand binding region [PF01094.30, score=42.4]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [RH, Score=632, Expect=0.0]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [RH, Score=640, Expect=0.0]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [RH, Score=610, Expect=0.0]} {Dmel: FBgn0085386, CG34357, [RH, Score=642, Expect=0.0]} {Celegans: WBGene00001542, gcy-17, Receptor-type guanylate cyclase gcy-17, [RH, Score=452, Expect=2e-140]} {Smed: dd_Smed_v6_33097_0_1, dd_Smed_v6_33097_0_1, [RH, Score=707, Expect=0.0]} {RNA1310_64185} {RNA815_57442} Mlig455_067577 {REF} {Length: 474} {Human: ENSG00000132518, GUCY2D, guanylate cyclase 2D, retinal, [Score=66.2, Expect=9e-13]} {Mouse: ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=65.1, Expect=2e-12]} {Dmel: FBgn0085386, CG34357, [Score=62.0, Expect=1e-11]} {Celegans: WBGene00020131, gcy-28, Receptor-type guanylate cyclase gcy-28, [Score=44.7, Expect=9e-06]} {Smed: dd_Smed_v6_39042_0_1, dd_Smed_v6_39042_0_1, [Score=98.2, Expect=2e-25]} {RNA1310_101378} |
42. | MligTC455_42580 | 98 | 2.04 | Mlig455_014929, Mlig455_045199 | Neo: - Age: - |
NKX2-2 | 2.614 | - | - | 0.746 | 0.884 | 0.984 | - | Mlig455_014929 {REF} {Length: 1652} {Pfam: Homeodomain [PF00046.31, score=70.3]} {Human: ENSG00000125820, NKX2-2, NK2 homeobox 2, [RH, Score=138, Expect=2e-37]} {Mouse: ENSMUSG00000027434, Nkx2-2, NK2 homeobox 2, [RH, Score=139, Expect=1e-37]} {Dmel: FBgn0261930, vnd, ventral nervous system defective, [RH, Score=138, Expect=4e-35]} {Celegans: WBGene00000445, ceh-22, Homeobox protein ceh-22, [RH, Score=107, Expect=6e-26]} {Smed: dd_Smed_v6_2716_0_1, dd_Smed_v6_2716_0_1, [RH, Score=120, Expect=1e-29]} {RNA1310_42496} {RNA815_52707} Mlig455_045199 {REF} {Length: 1211} {Pfam: Homeodomain [PF00046.31, score=71.0]} {Human: ENSG00000125820, NKX2-2, NK2 homeobox 2, [RH, Score=139, Expect=6e-39]} {Mouse: ENSMUSG00000027434, Nkx2-2, NK2 homeobox 2, [RH, Score=139, Expect=3e-39]} {Dmel: FBgn0261930, vnd, ventral nervous system defective, [RH, Score=138, Expect=1e-36]} {Celegans: WBGene00000445, ceh-22, Homeobox protein ceh-22, [RH, Score=108, Expect=2e-27]} {Smed: dd_Smed_v6_2716_0_1, dd_Smed_v6_2716_0_1, [RH, Score=120, Expect=7e-31]} {RNA1310_42496} {RNA815_52707} |
43. | MligTC455_37188 | 31 | 0.65 | Mlig455_000345 | Neo: - Age: - |
TRAF5 | 2.61 | - | - | 0.752 | 0.884 | 0.974 | - | Mlig455_000345 {REF} {Length: 892} {Human: ENSG00000082512, TRAF5, TNF receptor associated factor 5, [Score=67.8, Expect=2e-12]; ENSG00000076604, TRAF4, TNF receptor associated factor 4, [Score=65.5, Expect=8e-12]} {Mouse: ENSMUSG00000111385, Traf5, TNF receptor-associated factor 5, [Score=75.1, Expect=8e-16]; ENSMUSG00000026637, Traf5, TNF receptor-associated factor 5, [Score=75.1, Expect=8e-16]} {Dmel: FBgn0026319, Traf4, TNF-receptor-associated factor 4, [Score=65.1, Expect=6e-12]} {Celegans: WBGene00006612, trf-1, TNF Receptor Associated Factor (TRAF) homolog; TRF-1, [Score=92.0, Expect=3e-21]} {Smed: dd_Smed_v6_13517_0_1, dd_Smed_v6_13517_0_1, [Score=108, Expect=5e-27]} |
44. | MligTC455_04854 | 57 | 1.18 | Mlig455_032030 | Neo: - Age: - Region-enriched R2: 5.099/0.03475 |
2.61 | - | - | 0.732 | 0.894 | 0.984 | - | Mlig455_032030 {REF} {Length: 1388} {RNA1310_84273} | |
45. | MligTC455_29412 | 46 | 0.96 | Mlig455_000627, Mlig455_008268, Mlig455_040614 | Neo: - Age: Up-Down-Up |
2.61 | - | - | 0.744 | 0.893 | 0.973 | - | Mlig455_000627 {REF} {Length: 1331} {RNA1310_62571} {RNA815_30942} Mlig455_008268 {REF} {Length: 1779} {RNA1509_47298} {RNA1310_98344} {RNA815_10804.1} Mlig455_040614 {REF} {Length: 1016} |
|
46. | MligTC455_22428 | 96 | 2.01 | Mlig455_011005 | Neo: - Age: - |
2.609 | - | - | 0.863 | 0.780 | 0.966 | - | Mlig455_011005 {REF} {Length: 3873} {Pfam: WS/DGAT C-terminal domain [PF06974.15, score=54.7]; Transcription factor IIA, alpha/beta subunit [PF03153.15, score=22.2]; Telomere-associated protein TERB2 [PF15101.8, score=20.0]; ZIP Zinc transporter [PF02535.24, score=18.7]; Ureide permease [PF07168.13, score=17.4]} {Smed: dd_Smed_v6_7004_0_1, dd_Smed_v6_7004_0_1, [Score=151, Expect=2e-37]} {RNA1310_98904} | |
47. | MligTC455_52629 | 472 | 9.83 | Mlig455_059435 | Neo: - Age: Down-Up-Up Region-specific R2: 6.775 Region-enriched R2: 6.727/0.00002 |
2.609 | - | - | 0.723 | 0.898 | 0.988 | - | Mlig455_059435 {REF} {Length: 726} {RNA1509_48505} {RNA1310_62885} {RNA815_39881} | |
48. | MligTC455_31933 | 105 | 2.18 | Mlig455_062083 | Neo: - Age: - |
ANGPTL1 | 2.606 | - | - | - | 0.721 | 0.916 | 0.969 | Mlig455_062083 {REF} {Length: 1024} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=156.7]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=135, Expect=7e-36]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=132, Expect=2e-34]; ENSG00000101280, ANGPT4, angiopoietin 4, [Score=132, Expect=9e-35]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=137, Expect=1e-36]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=132, Expect=4e-35]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=131, Expect=1e-34]} {Dmel: FBgn0034160, CG5550, [Score=130, Expect=2e-36]} {Celegans: WBGene00020516, T15B7.1, [Score=73.9, Expect=9e-15]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=126, Expect=2e-32]} {RNA1509_14033} {RNA1310_32107.2} {RNA815_17173.3} |
49. | MligTC455_17363 | 62 | 1.28 | Mlig455_003936 | Neo: - Age: - |
2.602 | - | - | 0.725 | 0.898 | 0.979 | - | Mlig455_003936 {REF} {Length: 1252} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=45.9]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=26.4]} {RNA1310_47889} {RNA815_24646} | |
50. | MligTC455_43140 | 1841 | 38.34 | Mlig455_031799, Mlig455_047599 | Neo: - Age: - Region-enriched R8: 3.365/0.00001 |
GNAS | 2.602 | - | - | - | 0.880 | 0.968 | 0.754 | Mlig455_031799 {REF} {Length: 1853} {Pfam: G-protein alpha subunit [PF00503.22, score=342.0]; ADP-ribosylation factor family [PF00025.23, score=58.4]; Gtr1/RagA G protein conserved region [PF04670.14, score=24.9]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=19.9]} {Human: ENSG00000087460, GNAS, GNAS complex locus, [RH, Score=514, Expect=0.0]; ENSG00000141404, GNAL, G protein subunit alpha L, [RH, Score=506, Expect=1e-179]} {Mouse: ENSMUSG00000027523, Gnas, GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus, [RH, Score=512, Expect=0.0]; ENSMUSG00000024524, Gnal, guanine nucleotide binding protein, alpha stimulating, olfactory type, [RH, Score=510, Expect=0.0]} {Dmel: FBgn0001123, Galphas, G protein alpha s subunit, [RH, Score=511, Expect=0.0]} {Celegans: WBGene00001745, gsa-1, G protein, Subunit Alpha, [RH, Score=469, Expect=2e-165]} {Smed: dd_Smed_v6_6167_0_1, dd_Smed_v6_6167_0_1, [RH, Score=540, Expect=0.0]} {RNA1509_55942} {RNA1310_13501} {RNA815_7904} Mlig455_047599 {REF} {Length: 1095} {RNA1509_25915, RNA1509_33730} {RNA1310_45973, RNA1509_25915, RNA1509_33730} {RNA1509_25915, RNA1509_33730, RNA815_22813} |
51. | MligTC455_40388 | 23 | 0.47 | Mlig455_019615 | Neo: - Age: - |
2.597 | - | - | 0.713 | 0.897 | 0.987 | - | Mlig455_019615 {REF} {Length: 2102} {Pfam: Sushi repeat (SCR repeat) [PF00084.22, score=34.2]} {Smed: dd_Smed_v6_41498_0_1, dd_Smed_v6_41498_0_1, [Score=144, Expect=9e-37]} {RNA1310_29891} {RNA815_15562} | |
52. | MligTC455_53546 | 130 | 2.72 | Mlig455_013326, Mlig455_013334 | Neo: - Age: - Region-enriched R2: 6.753/0.01892 |
MMP9 | 2.597 | - | - | 0.758 | 0.865 | 0.974 | - | Mlig455_013326 {REF} {Length: 1449} {Pfam: Fibronectin type II domain [PF00040.21, score=92.5]} {Human: ENSG00000100985, MMP9, matrix metallopeptidase 9, [RH, Score=87.8, Expect=3e-18]} {Mouse: ENSMUSG00000017737, Mmp9, matrix metallopeptidase 9, [RH, Score=82.4, Expect=1e-16]; ENSMUSG00000031740, Mmp2, matrix metallopeptidase 2, [RH, Score=78.6, Expect=2e-15]} {Smed: dd_Smed_v6_14558_0_1, dd_Smed_v6_14558_0_1, [RH, Score=138, Expect=3e-38]} {RNA1310_38631} {RNA815_51136} Mlig455_013334 {REF} {Length: 1398} {Pfam: Fibronectin type II domain [PF00040.21, score=92.1]} {Human: ENSG00000100985, MMP9, matrix metallopeptidase 9, [RH, Score=89.4, Expect=1e-18]} {Mouse: ENSMUSG00000017737, Mmp9, matrix metallopeptidase 9, [RH, Score=84.0, Expect=4e-17]} {Smed: dd_Smed_v6_12601_0_1, dd_Smed_v6_12601_0_1, [RH, Score=140, Expect=2e-38]} {RNA1310_38631} {RNA815_51136} |
53. | MligTC455_45033 | 23 | 0.47 | Mlig455_060160 | Neo: - Age: - |
2.595 | - | - | 0.700 | - | 0.920 | 0.975 | Mlig455_060160 {REF} {Length: 755} {Pfam: PAN domain [PF00024.28, score=25.5]} {RNA1310_44307} {RNA815_33128} | |
54. | MligTC455_50694 | 602 | 12.54 | Mlig455_058794, Mlig455_070066 | Neo: - Age: Down-Down-Up Region-specific R2: 5.478 Region-enriched R2: 3.805/0.01454 |
2.591 | - | - | 0.709 | 0.903 | 0.979 | - | Mlig455_058794 {REF} {Length: 776} {RNA1310_76208} {RNA815_49041} Mlig455_070066 {REF} {Length: 781} {RNA1310_76208} {RNA815_49041} |
|
55. | MligTC455_49863 | 62 | 1.29 | Mlig455_019320, Mlig455_019542 | Neo: - Age: - |
SHOX2 | 2.583 | - | - | 0.764 | 0.830 | 0.989 | - | Mlig455_019320 {REF} {Length: 1251} {Pfam: Homeodomain [PF00046.31, score=83.4]; Homeobox KN domain [PF05920.13, score=23.0]} {Human: ENSG00000168779, SHOX2, short stature homeobox 2, [Score=88.2, Expect=5e-21]; ENSG00000185960, SHOX, short stature homeobox, [Score=86.3, Expect=7e-20]} {Mouse: ENSMUSG00000027833, Shox2, short stature homeobox 2, [Score=88.2, Expect=3e-21]} {Dmel: FBgn0085396, CG34367, [Score=89.4, Expect=7e-21]} {Celegans: WBGene00006744, unc-4, Homeobox protein unc-4, [Score=84.0, Expect=2e-19]} {Smed: dd_Smed_v6_22163_0_1, dd_Smed_v6_22163_0_1, [Score=87.0, Expect=8e-20]} {RNA1310_51707} {RNA815_41055} Mlig455_019542 {REF} {Length: 1249} {Pfam: Homeodomain [PF00046.31, score=83.4]; Homeobox KN domain [PF05920.13, score=23.0]} {Human: ENSG00000168779, SHOX2, short stature homeobox 2, [Score=88.6, Expect=4e-21]; ENSG00000185960, SHOX, short stature homeobox, [Score=86.3, Expect=6e-20]} {Mouse: ENSMUSG00000027833, Shox2, short stature homeobox 2, [Score=88.6, Expect=3e-21]} {Dmel: FBgn0085396, CG34367, [Score=89.4, Expect=7e-21]} {Celegans: WBGene00006744, unc-4, Homeobox protein unc-4, [Score=86.7, Expect=3e-20]} {Smed: dd_Smed_v6_22163_0_1, dd_Smed_v6_22163_0_1, [Score=87.0, Expect=8e-20]} {RNA1310_51707} {RNA815_41055} |
56. | MligTC455_11109 | 30 | 0.62 | Mlig455_043718, Mlig455_043804 | Neo: - Age: Up-Down-Down |
2.58 | - | - | 0.720 | 0.884 | 0.976 | - | Mlig455_043718 {REF} {Length: 1591} {RNA1310_49834.1} {RNA815_39415} Mlig455_043804 {REF} {Length: 1594} {RNA1310_49834.2} {RNA815_39415} |
|
57. | MligTC455_27826 | 3365 | 70.11 | Mlig455_012369 | Neo: - Age: logFC(26M/2M)=-0.363 Region-specific R2: 3.166 Region-enriched R8: 2.483/0.00000 Regeneration-depleted BL: -1.955 |
2.58 | - | - | 0.769 | 0.859 | 0.952 | - | Mlig455_012369 {REF} {Length: 1066} {Pfam: Domain of unknown function (DUF4905) [PF16248.7, score=18.4]} {RNA1509_28537, RNA1509_7615} {RNA1310_59305, RNA1509_28537, RNA1509_7615} {RNA1509_28537, RNA1509_7615, RNA815_42608} | |
58. | MligTC455_45913 | 4034 | 84.05 | Mlig455_017927 | Neo: - Age: Down-Up-Up Region-specific R2: 3.031 Region-enriched R2: 2.341/0.00000 Regeneration-downregulated BL: -1.976 Regeneration-depleted BL: -1.976 |
2.57 | - | - | 0.785 | 0.829 | 0.956 | - | Mlig455_017927 {REF} {Length: 1006} {RNA1509_22540, RNA1509_32903, RNA1509_3805} {RNA1310_38334, RNA1509_22540, RNA1509_32903, RNA1509_3805} {RNA1509_22540, RNA1509_32903, RNA1509_3805, RNA815_18393} | |
59. | MligTC455_37701 | 47 | 0.98 | Mlig455_029831 | Neo: - Age: - Region-enriched R2: 8.298/0.02665 |
2.567 | - | - | 0.718 | 0.893 | 0.956 | - | Mlig455_029831 {REF} {Length: 724} {RNA1310_73844} | |
60. | MligTC455_53869 | 27 | 0.57 | Mlig455_060247 | Neo: - Age: - |
CHDH | 2.562 | - | - | 0.725 | 0.878 | 0.959 | - | Mlig455_060247 {REF} {Length: 2837} {Pfam: GMC oxidoreductase [PF00732.21, score=82.3]; GMC oxidoreductase [PF05199.15, score=61.5]; FAD dependent oxidoreductase [PF01266.26, score=20.3]; Lycopene cyclase protein [PF05834.14, score=18.0]} {Human: ENSG00000016391, CHDH, choline dehydrogenase, [Score=101, Expect=6e-22]} {Mouse: ENSMUSG00000015970, Chdh, choline dehydrogenase, [Score=103, Expect=9e-23]} {Dmel: FBgn0037896, ninaG, [Score=116, Expect=3e-27]} {Celegans: WBGene00007917, C34C6.4, [Score=65.9, Expect=4e-11]} {Smed: dd_Smed_v6_13047_0_2, dd_Smed_v6_13047_0_2, [RH, Score=166, Expect=2e-44]} {RNA1310_47881.1} |
61. | MligTC455_40340 | 201 | 4.19 | Mlig455_021026, Mlig455_021062 | Neo: - Age: - |
2.558 | - | - | 0.750 | 0.819 | 0.989 | - | Mlig455_021026 {REF} {Length: 1609} {RNA1310_21018} {RNA815_22069} Mlig455_021062 {REF} {Length: 1582} {RNA1310_21018} {RNA815_22069} |
|
62. | MligTC455_27799 | 414 | 8.62 | Mlig455_004285, Mlig455_004370 | Neo: - Age: Down-Up-Down Region-specific R2: 3.850 Region-enriched R2: 5.047/0.00000 |
2.554 | - | - | 0.700 | 0.897 | 0.957 | - | Mlig455_004285 {REF} {Length: 650} {RNA1509_56105} {RNA1310_32410} {RNA815_17871.1} Mlig455_004370 {REF} {Length: 1653} {RNA1509_56105} {RNA1310_32410} {RNA815_17871.1} |
|
63. | MligTC455_44354 | 1240 | 25.82 | Mlig455_001577 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.349 Region-specific R2: 5.143 Region-enriched R2: 4.498/0.00000 Regeneration-downregulated R2: -2.807 Regeneration-depleted R2: -2.807 |
2.554 | - | - | 0.726 | 0.851 | 0.977 | - | Mlig455_001577 {REF} {Length: 1028} {RNA1509_23470, RNA1509_33941, RNA1509_57202} {RNA1310_49541.2, RNA1509_23470, RNA1509_33941, RNA1509_57202} {RNA1509_23470, RNA1509_33941, RNA1509_57202, RNA815_59782} | |
64. | MligTC455_21719 | 441 | 9.18 | Mlig455_025497, Mlig455_025520, Mlig455_070509 | Neo: - Age: - |
SLC6A1 | 2.552 | - | - | 0.775 | - | 0.955 | 0.822 | Mlig455_025497 {REF} {Length: 3353} {Pfam: Sodium:neurotransmitter symporter family [PF00209.20, score=655.7]} {Human: ENSG00000157103, SLC6A1, solute carrier family 6 member 1, [RH, Score=592, Expect=0.0]} {Mouse: ENSMUSG00000030310, Slc6a1, solute carrier family 6 (neurotransmitter transporter, GABA), member 1, [RH, Score=592, Expect=0.0]} {Dmel: FBgn0039915, Gat, GABA transporter, [RH, Score=590, Expect=0.0]} {Celegans: WBGene00004910, snf-11, Transporter, [RH, Score=599, Expect=0.0]} {Smed: dd_Smed_v6_8169_0_1, dd_Smed_v6_8169_0_1, [RH, Score=652, Expect=0.0]} {RNA1509_27603} {RNA1310_5653.1} {RNA815_1806} Mlig455_025520 {REF} {Length: 3631} {Pfam: Sodium:neurotransmitter symporter family [PF00209.20, score=655.7]} {Human: ENSG00000157103, SLC6A1, solute carrier family 6 member 1, [RH, Score=592, Expect=0.0]} {Mouse: ENSMUSG00000030310, Slc6a1, solute carrier family 6 (neurotransmitter transporter, GABA), member 1, [RH, Score=592, Expect=0.0]} {Dmel: FBgn0039915, Gat, GABA transporter, [RH, Score=590, Expect=0.0]} {Celegans: WBGene00004910, snf-11, Transporter, [RH, Score=599, Expect=0.0]} {Smed: dd_Smed_v6_8169_0_1, dd_Smed_v6_8169_0_1, [RH, Score=652, Expect=0.0]} {RNA1509_27603} {RNA1310_5653.1, RNA1509_27603} {RNA1509_27603, RNA815_1806} Mlig455_070509 {REF} {Length: 3425} {Pfam: Sodium:neurotransmitter symporter family [PF00209.20, score=631.8]} {Human: ENSG00000157103, SLC6A1, solute carrier family 6 member 1, [RH, Score=576, Expect=0.0]} {Mouse: ENSMUSG00000030310, Slc6a1, solute carrier family 6 (neurotransmitter transporter, GABA), member 1, [RH, Score=577, Expect=0.0]} {Dmel: FBgn0039915, Gat, GABA transporter, [RH, Score=575, Expect=0.0]} {Celegans: WBGene00004910, snf-11, Transporter, [RH, Score=583, Expect=0.0]} {Smed: dd_Smed_v6_8169_0_1, dd_Smed_v6_8169_0_1, [RH, Score=636, Expect=0.0]} {RNA1509_27603} {RNA1310_5653.1} {RNA815_1806} |
65. | MligTC455_43390 | 28 | 0.59 | Mlig455_064273 | Neo: - Age: Down-Up-Down |
PRKAR2A | 2.55 | - | - | 0.850 | 0.705 | 0.995 | - | Mlig455_064273 {REF} {Length: 2394} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=122.5]; Regulatory subunit of type II PKA R-subunit [PF02197.19, score=40.5]} {Human: ENSG00000114302, PRKAR2A, protein kinase cAMP-dependent type II regulatory subunit alpha, [Score=305, Expect=2e-100]; ENSG00000005249, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=296, Expect=8e-97]; ENSG00000284096, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=296, Expect=8e-97]} {Mouse: ENSMUSG00000032601, Prkar2a, protein kinase, cAMP dependent regulatory, type II alpha, [Score=314, Expect=6e-104]} {Dmel: FBgn0022382, Pka-R2, Protein kinase, cAMP-dependent, regulatory subunit type 2, [Score=335, Expect=1e-112]} {Celegans: WBGene00002190, kin-2, cAMP-dependent protein kinase regulatory subunit, [Score=219, Expect=2e-68]} {Smed: dd_Smed_v6_4188_0_1, dd_Smed_v6_4188_0_1, [Score=335, Expect=5e-113]} {RNA1509_34470} {RNA1310_27777} {RNA815_5628} |
66. | MligTC455_38162 | 710 | 14.8 | Mlig455_045004 | Neo: - Age: Down-Up-Up Region-specific R2: 5.269 Region-enriched R2: 5.838/0.00000 Regeneration-downregulated R2: -4.412 Regeneration-depleted R2: -4.412 |
2.545 | - | - | 0.740 | 0.840 | 0.965 | - | Mlig455_045004 {REF} {Length: 659} {Smed: dd_Smed_v6_4046_0_1, dd_Smed_v6_4046_0_1, [Score=57.8, Expect=2e-12]} {RNA1509_50998, RNA1509_57106} {RNA1310_56015, RNA1509_50998, RNA1509_57106} {RNA1509_50998, RNA1509_57106, RNA815_29915} | |
67. | MligTC455_12511 | 68 | 1.42 | Mlig455_017662 | Neo: - Age: - |
2.537 | - | - | 0.774 | 0.775 | 0.988 | - | Mlig455_017662 {REF} {Length: 906} {RNA1310_37507} {RNA815_32171} | |
68. | MligTC455_44050 | 2086 | 43.46 | Mlig455_028045, Mlig455_028051 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.242 Region-specific R2: 6.161 Region-enriched R2: 7.072/0.00000 |
2.53 | - | - | 0.790 | - | 0.774 | 0.966 | Mlig455_028045 {REF} {Length: 1156} {RNA1509_31459, RNA1509_3903} {RNA1310_2730.2, RNA1509_31459, RNA1509_3903} {RNA1509_31459, RNA1509_3903, RNA815_7682} Mlig455_028051 {REF} {Length: 871} {NoTransDecoderORF} {RNA1509_3903} {RNA1310_15260} {RNA815_7682} |
|
69. | MligTC455_20953 | 115 | 2.4 | Mlig455_002904 | Neo: - Age: - Region-enriched R2: 5.041/0.00953 |
2.521 | - | - | 0.762 | 0.809 | 0.950 | - | Mlig455_002904 {REF} {Length: 1514} {RNA1310_19276} {RNA815_20827} | |
70. | MligTC455_41988 | 81 | 1.68 | Mlig455_049279, Mlig455_050624 | Neo: - Age: - |
2.521 | - | - | 0.731 | 0.828 | 0.962 | - | Mlig455_049279 {REF} {Length: 6361} {Pfam: Innexin [PF00876.20, score=408.1]} {Dmel: FBgn0085387, shakB, shaking B, [RH, Score=133, Expect=1e-34]} {Celegans: WBGene00002123, inx-1, Innexin, [Score=341, Expect=5e-114]} {Smed: dd_Smed_v6_11077_0_2, dd_Smed_v6_11077_0_2, [RH, Score=483, Expect=3e-168]} {RNA1509_51082} {RNA1310_22380} {RNA815_25566} Mlig455_050624 {REF} {Length: 2845} {Pfam: Innexin [PF00876.20, score=408.0]} {Dmel: FBgn0085387, shakB, shaking B, [RH, Score=133, Expect=2e-34]} {Celegans: WBGene00002123, inx-1, Innexin, [Score=342, Expect=3e-114]} {Smed: dd_Smed_v6_11077_0_2, dd_Smed_v6_11077_0_2, [RH, Score=484, Expect=1e-168]} {RNA1509_51082} {RNA1310_22380} {RNA815_1848.2} |
|
71. | MligTC455_46924 | 1562 | 32.53 | Mlig455_042561 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.240 Region-enriched R2: 5.226/0.00021 |
PI16 | 2.508 | - | - | 0.790 | - | 0.961 | 0.757 | Mlig455_042561 {REF} {Length: 1929} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=59.8]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=75.5, Expect=4e-14]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=78.6, Expect=3e-15]; ENSMUSG00000020213, Glipr1l1, GLI pathogenesis-related 1 like 1, [Score=75.1, Expect=5e-15]} {Dmel: FBgn0038126, CG8483, [Score=65.9, Expect=2e-11]} {Celegans: WBGene00003055, lon-1, LONg, [Score=65.9, Expect=7e-12]} {Smed: dd_Smed_v6_2021_0_1, dd_Smed_v6_2021_0_1, [RH, Score=140, Expect=2e-36]} {RNA1509_33691, RNA1509_4403} {RNA1310_19427.1, RNA1509_33691, RNA1509_4403} {RNA1509_33691, RNA1509_4403, RNA815_7689.1} |
72. | MligTC455_46566 | 167 | 3.47 | Mlig455_030556 | Neo: - Age: - Region-enriched R2: 2.352/0.01128 |
2.505 | - | - | 0.709 | 0.823 | 0.973 | - | Mlig455_030556 {REF} {Length: 2003} {Smed: dd_Smed_v6_3795_0_1, dd_Smed_v6_3795_0_1, [Score=86.7, Expect=8e-19]} {RNA1509_3114} {RNA1310_34234} {RNA815_19594} | |
73. | MligTC455_51101 | 25 | 0.51 | Mlig455_015276 | Neo: - Age: - Region-enriched R4: 3.968/0.02941 |
CALM2 | 2.505 | - | - | 0.706 | 0.841 | 0.958 | - | Mlig455_015276 {REF} {Length: 810} {Pfam: EF hand [PF00036.34, score=113.6]; EF-hand domain pair [PF13499.8, score=105.2]; EF-hand domain [PF13405.8, score=85.5]; EF-hand domain pair [PF13833.8, score=81.8]; EF hand [PF13202.8, score=77.7]; EF-hand domain [PF14658.8, score=48.9]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=31.2]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=25.6]; Dockerin type I domain [PF00404.20, score=23.9]; Uncharacterised protein family (UPF0154) [PF03672.15, score=22.9]; SurA N-terminal domain [PF13623.8, score=18.8]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=169, Expect=2e-53]; ENSG00000198668, CALM1, calmodulin 1, [Score=167, Expect=4e-53]; ENSG00000160014, CALM3, calmodulin 3, [Score=167, Expect=4e-53]; ENSG00000178363, CALML3, calmodulin like 3, [Score=162, Expect=2e-51]} {Mouse: ENSMUSG00000019370, Calm3, calmodulin 3, [Score=167, Expect=2e-53]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=167, Expect=2e-53]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=167, Expect=2e-53]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=163, Expect=9e-52]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=167, Expect=1e-53]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=167, Expect=2e-53]} {Smed: dd_Smed_v6_255_0_1, dd_Smed_v6_255_0_1, [Score=167, Expect=1e-53]} {RNA1310_38833} {RNA815_22576} |
74. | MligTC455_50455 | 972 | 20.25 | Mlig455_070346 | Neo: - Age: - Region-specific R2: 4.855 Region-enriched R2: 5.186/0.00000 |
2.499 | - | - | 0.700 | 0.847 | 0.952 | - | Mlig455_070346 {REF} {Length: 932} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=34.4]; Nematode insulin-related peptide beta type [PF03488.16, score=21.4]} {RNA1509_18514, RNA1509_58074} {RNA1310_51990, RNA1509_18514, RNA1509_58074} {RNA1509_18514, RNA1509_58074, RNA815_25071} | |
75. | MligTC455_21974 | 1557 | 32.43 | Mlig455_021416 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=0.546 Region-specific R2: 3.190 Region-enriched R2: 2.971/0.00000 |
BMPER | 2.496 | - | - | 0.738 | 0.787 | 0.971 | - | Mlig455_021416 {REF} {Length: 22453} {Pfam: Domain of unknown function (DUF1943) [PF09172.13, score=157.5]; von Willebrand factor type D domain [PF00094.27, score=57.2]; Domain of Unknown Function (DUF1081) [PF06448.13, score=32.7]; C8 domain [PF08742.13, score=24.8]; Neurensin [PF14927.8, score=24.5]} {Human: ENSG00000164619, BMPER, BMP binding endothelial regulator, [Score=79.0, Expect=2e-13]; ENSG00000135253, KCP, kielin/chordin-like protein, [Score=79.0, Expect=3e-13]; ENSG00000275395, FCGBP, Fc fragment of IgG binding protein, [Score=76.6, Expect=2e-12]} {Mouse: ENSMUSG00000031963, Bmper, BMP-binding endothelial regulator, [Score=77.0, Expect=6e-13]} {Dmel: FBgn0032136, Apoltp, Apolipoprotein lipid transfer particle, [Score=226, Expect=7e-58]} {Smed: dd_Smed_v6_194_0_1, dd_Smed_v6_194_0_1, [Score=241, Expect=9e-63]} {RNA1509_31} {RNA1310_7.1} {RNA815_4} |
76. | MligTC455_46982 | 256 | 5.34 | Mlig455_044826 | Neo: - Age: - |
SYN3 | 2.496 | - | - | 0.733 | 0.794 | 0.969 | - | Mlig455_044826 {REF} {Length: 2562} {TRANSSPLICED} {Pfam: Synapsin, ATP binding domain [PF02750.16, score=168.9]} {Human: ENSG00000185666, SYN3, synapsin III, [RH, Score=176, Expect=7e-53]} {Mouse: ENSMUSG00000059602, Syn3, synapsin III, [Score=173, Expect=2e-49]; ENSMUSG00000037217, Syn1, synapsin I, [Score=170, Expect=6e-48]} {Dmel: FBgn0004575, Syn, Synapsin, [Score=186, Expect=1e-54]} {Celegans: WBGene00004913, snn-1, SyNapsiN; Synapsin, [Score=105, Expect=6e-26]} {Smed: dd_Smed_v6_3135_0_2, dd_Smed_v6_3135_0_2, [RH, Score=216, Expect=3e-68]} {RNA1310_32498} {RNA815_34432} |
77. | MligTC455_29100 | 53 | 1.11 | Mlig455_022386, Mlig455_022475 | Neo: - Age: - Region-enriched R2: 7.567/0.00114 |
KREMEN2 | 2.476 | - | - | 0.704 | 0.813 | 0.959 | - | Mlig455_022386 {REF} {Length: 4145} {tRNA: Val(CAC),pseudo, score=29.3} {Pfam: WSC domain [PF01822.21, score=45.2]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=48.5, Expect=3e-06]; ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=47.0, Expect=7e-06]} {RNA1509_55375} {RNA1310_18706} {RNA815_23500} Mlig455_022475 {REF} {Length: 3047} {Pfam: WSC domain [PF01822.21, score=46.0]; PAN domain [PF00024.28, score=23.9]} {Human: ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=51.2, Expect=4e-07]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=53.5, Expect=5e-08]} {RNA1509_47157} {RNA1310_35396.1} {RNA815_23500} |
78. | MligTC455_44904 | 1501 | 31.27 | Mlig455_021814 | Neo: - Age: Down-Up-Up Region-specific R2: 3.865 Region-enriched R2: 3.792/0.00000 |
2.465 | - | - | - | 0.763 | 0.970 | 0.732 | Mlig455_021814 {REF} {Length: 959} {RNA1509_15805} {RNA1310_67099.1, RNA1509_15805} {RNA1509_15805, RNA815_17533} | |
79. | MligTC455_50602 | 84 | 1.74 | Mlig455_065088 | Neo: - Age: - |
2.45 | - | - | 0.710 | 0.786 | 0.954 | - | Mlig455_065088 {REF} {Length: 2765} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=129.5]} {Smed: dd_Smed_v6_37545_0_1, dd_Smed_v6_37545_0_1, [Score=67.8, Expect=6e-12]} {RNA1310_8235} {RNA815_10456.1} | |
80. | MligTC455_21975 | 1445 | 30.1 | Mlig455_067235 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=0.598 Region-specific R2: 3.235 Region-enriched R2: 3.090/0.00000 |
BMPER | 2.428 | - | - | 0.709 | 0.756 | 0.963 | - | Mlig455_067235 {REF} {Length: 21751} {Pfam: von Willebrand factor type D domain [PF00094.27, score=57.1]; C8 domain [PF08742.13, score=24.9]; Neurensin [PF14927.8, score=24.8]} {Human: ENSG00000164619, BMPER, BMP binding endothelial regulator, [Score=80.9, Expect=4e-14]; ENSG00000135253, KCP, kielin/chordin-like protein, [Score=78.6, Expect=4e-13]; ENSG00000275395, FCGBP, Fc fragment of IgG binding protein, [Score=78.6, Expect=5e-13]} {Mouse: ENSMUSG00000031963, Bmper, BMP-binding endothelial regulator, [Score=78.6, Expect=2e-13]} {Dmel: FBgn0032136, Apoltp, Apolipoprotein lipid transfer particle, [Score=226, Expect=6e-58]} {Smed: dd_Smed_v6_194_0_1, dd_Smed_v6_194_0_1, [Score=244, Expect=8e-64]} {RNA1509_13513, RNA1509_26457, RNA1509_30456, RNA1509_31, RNA1509_5282} {RNA1310_7.1, RNA1509_13513, RNA1509_26457, RNA1509_30456, RNA1509_5282} {RNA1509_13513, RNA1509_26457, RNA1509_30456, RNA1509_5282, RNA815_4} |
81. | MligTC455_15184 | 33 | 0.69 | Mlig455_065087 | Neo: - Age: - |
2.427 | - | - | 0.724 | 0.712 | 0.991 | - | Mlig455_065087 {REF} {Length: 2555} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=183.3]} {Mouse: ENSMUSG00000030340, Scnn1a, sodium channel, nonvoltage-gated 1 alpha, [Score=48.5, Expect=1e-05]} {Celegans: WBGene00009073, delm-1, DEgenerin Linked to Mechanosensation, [Score=68.2, Expect=1e-11]} {Smed: dd_Smed_v6_37545_0_1, dd_Smed_v6_37545_0_1, [RH, Score=125, Expect=3e-30]} {RNA1310_11413} {RNA815_11497} | |
82. | MligTC455_51238 | 58 | 1.21 | Mlig455_011511 | Neo: - Age: - |
KCNMA1 | 2.394 | - | - | 0.713 | 0.704 | 0.977 | - | Mlig455_011511 {REF} {Length: 2300} {Pfam: Calcium-activated BK potassium channel alpha subunit [PF03493.20, score=100.8]; Ion channel [PF07885.18, score=29.2]} {Human: ENSG00000156113, KCNMA1, potassium calcium-activated channel subfamily M alpha 1, [Score=272, Expect=4e-80]} {Mouse: ENSMUSG00000063142, Kcnma1, potassium large conductance calcium-activated channel, subfamily M, alpha member 1, [Score=271, Expect=4e-79]} {Dmel: FBgn0003429, slo, slowpoke, [Score=180, Expect=8e-48]} {Celegans: WBGene00004830, slo-1, Calcium-activated potassium channel slo-1, [Score=269, Expect=9e-79]} {Smed: dd_Smed_v6_5509_0_1, dd_Smed_v6_5509_0_1, [Score=294, Expect=9e-88]} {RNA1310_5274} {RNA815_44227} |
83. | MligTC455_25588 | 1046 | 21.8 | Mlig455_029794 | Neo: - Age: - Region-enriched R2: 2.896/0.00002 |
2.39 | - | - | 0.714 | - | 0.716 | 0.960 | Mlig455_029794 {REF} {Length: 1354} {Pfam: Domain of unknown function (DUF4573) [PF15140.8, score=40.1]; Domain of unknown function (DUF1848) [PF08902.13, score=20.8]} {RNA1509_17753} {RNA1310_70608} {RNA815_1498.1} | |
84. | MligTC455_47913 | 139 | 2.89 | Mlig455_025678 | Neo: - Age: Up-Down-Up Region-enriched R2: 4.279/0.00526 |
1.98 | - | - | - | - | 0.992 | 0.988 | Mlig455_025678 {REF} {Length: 634} {RNA1310_78201} {RNA815_41088} | |
85. | MligTC455_45621 | 610 | 12.72 | Mlig455_041531 | Neo: - Age: - Region-specific R2: 5.645 Region-enriched R2: 4.169/0.00001 |
1.927 | - | - | - | - | 0.973 | 0.954 | Mlig455_041531 {REF} {Length: 1004} {Smed: dd_Smed_v6_2575_0_1, dd_Smed_v6_2575_0_1, [Score=45.1, Expect=4e-07]} {RNA1509_31982, RNA1509_8166} {RNA1310_46295, RNA1509_31982, RNA1509_8166} {RNA1509_31982, RNA1509_8166, RNA815_23543} | |
86. | MligTC455_11314 | 22 | 0.45 | Mlig455_008025 | Neo: - Age: - |
TRPC5 | 1.917 | - | - | 0.929 | - | 0.988 | - | Mlig455_008025 {REF} {Length: 3829} {Pfam: Transient receptor ion channel II [PF08344.13, score=100.2]; Ion transport protein [PF00520.33, score=93.1]; Polycystin cation channel [PF08016.14, score=32.4]; Ankyrin repeats (3 copies) [PF12796.9, score=30.9]; Ankyrin repeat [PF13606.8, score=23.9]; Ankyrin repeats (many copies) [PF13637.8, score=21.3]} {Human: ENSG00000072315, TRPC5, transient receptor potential cation channel subfamily C member 5, [Score=632, Expect=0.0]; ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [Score=615, Expect=0.0]} {Mouse: ENSMUSG00000041710, Trpc5, transient receptor potential cation channel, subfamily C, member 5, [Score=634, Expect=0.0]; ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [Score=615, Expect=0.0]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [Score=598, Expect=0.0]} {Celegans: WBGene00006614, trp-1, Transient-receptor-potential-like protein, [RH, Score=820, Expect=0.0]} {Smed: dd_Smed_v6_15627_0_1, dd_Smed_v6_15627_0_1, [Score=559, Expect=0.0]} {RNA1310_93280} {RNA815_44973} |
87. | MligTC455_12514 | 30 | 0.63 | Mlig455_037415 | Neo: - Age: - |
CHRNA6 | 1.917 | - | - | 0.957 | - | 0.960 | - | Mlig455_037415 {REF} {Length: 1606} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=77.5]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=77.4, Expect=4e-16]; ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=75.1, Expect=2e-15]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=73.9, Expect=7e-15]} {Mouse: ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=80.5, Expect=3e-17]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=84.7, Expect=7e-19]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=72.8, Expect=5e-15]} {Smed: dd_Smed_v6_23922_0_1, dd_Smed_v6_23922_0_1, [Score=82.0, Expect=3e-18]} {RNA1509_53098} {RNA1310_110770} {RNA815_49679} |
88. | MligTC455_13846 | 32 | 0.67 | Mlig455_013761 | Neo: - Age: - |
CALM2 | 1.911 | - | - | - | 0.927 | 0.984 | - | Mlig455_013761 {REF} {Length: 941} {Pfam: EF hand [PF00036.34, score=94.2]; EF-hand domain [PF13405.8, score=86.1]; EF-hand domain pair [PF13499.8, score=83.6]; EF hand [PF13202.8, score=77.1]; EF-hand domain pair [PF13833.8, score=42.5]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=31.3]; EF-hand domain [PF14658.8, score=23.8]; Ca2+ insensitive EF hand [PF08726.12, score=21.5]; Caleosin related protein [PF05042.15, score=21.3]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=60.1, Expect=1e-11]; ENSG00000160014, CALM3, calmodulin 3, [Score=60.1, Expect=1e-11]; ENSG00000198668, CALM1, calmodulin 1, [Score=60.1, Expect=1e-11]; ENSG00000178363, CALML3, calmodulin like 3, [Score=59.3, Expect=2e-11]} {Mouse: ENSMUSG00000001175, Calm1, calmodulin 1, [Score=60.5, Expect=1e-11]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=60.1, Expect=8e-12]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=60.1, Expect=8e-12]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=59.7, Expect=1e-11]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=60.8, Expect=3e-12]} {Celegans: WBGene00019352, K03A1.4, [Score=70.9, Expect=8e-16]} {Smed: dd_Smed_v6_15455_0_1, dd_Smed_v6_15455_0_1, [RH, Score=97.4, Expect=1e-26]} {RNA1310_47452} {RNA815_31258} |
89. | MligTC455_40406 | 59 | 1.23 | Mlig455_062481 | Neo: - Age: - |
CHRNA9 | 1.911 | - | - | - | 0.949 | 0.962 | - | Mlig455_062481 {REF} {Length: 3660} {TRANSSPLICED} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=153.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=111.8]} {Human: ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=205, Expect=2e-59]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=1e-57]; ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=201, Expect=7e-58]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=2e-57]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=1e-57]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=199, Expect=2e-57]; ENSG00000169684, CHRNA5, cholinergic receptor nicotinic alpha 5 subunit, [Score=199, Expect=4e-57]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=196, Expect=1e-54]} {Mouse: ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=209, Expect=4e-61]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=207, Expect=7e-60]; ENSMUSG00000035594, Chrna5, cholinergic receptor, nicotinic, alpha polypeptide 5, [Score=200, Expect=6e-58]} {Dmel: FBgn0032151, nAChRalpha6, nicotinic Acetylcholine Receptor alpha6, [Score=202, Expect=2e-58]} {Celegans: WBGene00000050, acr-11, AcetylCholine Receptor, [Score=192, Expect=7e-55]} {Smed: dd_Smed_v6_9503_0_1, dd_Smed_v6_9503_0_1, [RH, Score=449, Expect=5e-153]} {RNA1509_18288} {RNA1310_3728, RNA1509_18288} {RNA1509_18288, RNA815_3826.3} |
90. | MligTC455_19917 | 83 | 1.72 | Mlig455_057932, Mlig455_057967 | Neo: - Age: - |
1.909 | - | - | - | 0.924 | 0.985 | - | Mlig455_057932 {REF} {Length: 2189} {RNA1310_65401} {RNA815_48417} Mlig455_057967 {REF} {Length: 1876} {RNA1310_65401} {RNA815_48417} |
|
91. | MligTC455_18139 | 70 | 1.45 | Mlig455_010809 | Neo: - Age: logFC(26M/2M)=-0.809 Region-enriched R2: 6.868/0.00081 |
TRPC5 | 1.905 | - | - | - | 0.938 | 0.967 | - | Mlig455_010809 {REF} {Length: 4442} {Pfam: Ion transport protein [PF00520.33, score=98.6]; Transient receptor ion channel II [PF08344.13, score=94.3]; Polycystin cation channel [PF08016.14, score=49.0]; Ankyrin repeats (many copies) [PF13637.8, score=37.1]; Ankyrin repeats (3 copies) [PF12796.9, score=33.2]; Ankyrin repeat [PF13606.8, score=25.4]; Ankyrin repeats (many copies) [PF13857.8, score=24.1]; Ankyrin repeat [PF00023.32, score=23.2]} {Human: ENSG00000072315, TRPC5, transient receptor potential cation channel subfamily C member 5, [RH, Score=743, Expect=0.0]; ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [RH, Score=740, Expect=0.0]} {Mouse: ENSMUSG00000041710, Trpc5, transient receptor potential cation channel, subfamily C, member 5, [RH, Score=744, Expect=0.0]; ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [RH, Score=740, Expect=0.0]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [RH, Score=848, Expect=0.0]} {Celegans: WBGene00006615, trp-2, TRP (Transient receptor potential) channel family; TRP homlogous cation channel protein, [RH, Score=694, Expect=0.0]} {Smed: dd_Smed_v6_20495_0_1, dd_Smed_v6_20495_0_1, [RH, Score=1017, Expect=0.0]} {RNA1509_34138} {RNA1310_12839, RNA1509_34138} {RNA1509_34138, RNA815_17637} |
92. | MligTC455_42391 | 1050 | 21.88 | Mlig455_010516, Mlig455_061820, Mlig455_061856, Mlig455_061864 | Neo: - Age: Down-Up-Up |
1.899 | - | - | - | 0.915 | 0.984 | - | Mlig455_010516 {REF} {Length: 729} {RNA1509_38791} {RNA1310_69853, RNA1509_38791} {RNA1509_38791, RNA815_39199} Mlig455_061820 {REF} {Length: 705} {RNA1509_38791} {RNA1310_69853} {RNA815_39199} Mlig455_061856 {REF} {Length: 708} {RNA1509_38791} {RNA1310_69853} {RNA815_39199} Mlig455_061864 {REF} {Length: 1146} {RNA1509_38791} {RNA1310_69853} {RNA815_39199} |
|
93. | MligTC455_31104 | 22 | 0.46 | Mlig455_040032, Mlig455_070983 | Neo: - Age: - |
SYT17 | 1.898 | - | - | 0.914 | - | 0.984 | - | Mlig455_040032 {REF} {Length: 2712} {Pfam: C2 domain [PF00168.32, score=79.2]} {Human: ENSG00000103528, SYT17, synaptotagmin 17, [Score=127, Expect=1e-30]} {Mouse: ENSMUSG00000058420, Syt17, synaptotagmin XVII, [Score=126, Expect=1e-30]} {Dmel: FBgn0028400, Syt4, Synaptotagmin 4, [Score=88.6, Expect=2e-18]} {Celegans: WBGene00004922, snt-2, Synaptotagmin 2, [Score=94.0, Expect=1e-20]} {Smed: dd_Smed_v6_19213_0_1, dd_Smed_v6_19213_0_1, [Score=96.7, Expect=3e-21]} {RNA1310_17303} Mlig455_070983 {REF} {Length: 1947} {Pfam: C2 domain [PF00168.32, score=79.2]} {Human: ENSG00000103528, SYT17, synaptotagmin 17, [Score=127, Expect=1e-30]} {Mouse: ENSMUSG00000058420, Syt17, synaptotagmin XVII, [Score=126, Expect=1e-30]} {Dmel: FBgn0028400, Syt4, Synaptotagmin 4, [Score=88.6, Expect=2e-18]} {Celegans: WBGene00004922, snt-2, Synaptotagmin 2, [Score=94.0, Expect=1e-20]} {Smed: dd_Smed_v6_19213_0_1, dd_Smed_v6_19213_0_1, [Score=96.7, Expect=3e-21]} {RNA1310_17303} |
94. | MligTC455_33394 | 29 | 0.6 | Mlig455_020353, Mlig455_041292 | Neo: - Age: - |
RASGRP1, RASGRP3 | 1.897 | - | - | - | 0.928 | 0.969 | - | Mlig455_020353 {REF} {Length: 2230} {Pfam: RasGEF domain [PF00617.21, score=61.8]; Phorbol esters/diacylglycerol binding domain (C1 domain) [PF00130.24, score=51.4]; EF hand [PF00036.34, score=33.2]; EF-hand domain [PF13405.8, score=32.5]; EF-hand domain pair [PF13499.8, score=28.5]; EF hand [PF13202.8, score=28.0]} {Human: ENSG00000152689, RASGRP3, RAS guanyl releasing protein 3, [Score=360, Expect=2e-115]; ENSG00000172575, RASGRP1, RAS guanyl releasing protein 1, [Score=349, Expect=6e-110]} {Mouse: ENSMUSG00000071042, Rasgrp3, RAS, guanyl releasing protein 3, [Score=356, Expect=2e-114]} {Dmel: FBgn0003093, Pkc98E, Protein C kinase 98E, [Score=65.1, Expect=9e-11]} {Celegans: WBGene00009100, rgef-1, Rap Guanine nucleotide Exchange Factor homolog, [Score=302, Expect=3e-94]} {Smed: dd_Smed_v6_15742_0_2, dd_Smed_v6_15742_0_2, [Score=270, Expect=3e-85]} {RNA1310_83329} Mlig455_041292 {REF} {Length: 3588} {Pfam: RasGEF domain [PF00617.21, score=145.2]; Phorbol esters/diacylglycerol binding domain (C1 domain) [PF00130.24, score=52.4]; EF hand [PF00036.34, score=34.0]; EF-hand domain [PF13405.8, score=33.3]; EF-hand domain pair [PF13499.8, score=30.9]; EF hand [PF13202.8, score=29.5]; EF-hand domain pair [PF13833.8, score=19.2]} {Human: ENSG00000172575, RASGRP1, RAS guanyl releasing protein 1, [RH, Score=451, Expect=8e-148]} {Mouse: ENSMUSG00000071042, Rasgrp3, RAS, guanyl releasing protein 3, [RH, Score=453, Expect=2e-150]; ENSMUSG00000027347, Rasgrp1, RAS guanyl releasing protein 1, [RH, Score=438, Expect=3e-143]} {Dmel: FBgn0034158, CG5522, [Score=95.9, Expect=3e-20]} {Celegans: WBGene00009100, rgef-1, Rap Guanine nucleotide Exchange Factor homolog, [Score=416, Expect=2e-136]} {Smed: dd_Smed_v6_15742_0_2, dd_Smed_v6_15742_0_2, [RH, Score=288, Expect=3e-91]} {RNA1509_53196} {RNA1310_34349} {RNA815_31634} |
95. | MligTC455_21583 | 64 | 1.33 | Mlig455_001407, Mlig455_064265 | Neo: - Age: - |
PDE8A | 1.89 | - | - | - | 0.909 | 0.981 | - | Mlig455_001407 {REF} {Length: 4083} {TRANSSPLICED} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=278.7]; PAS domain [PF13426.9, score=22.9]} {Human: ENSG00000073417, PDE8A, phosphodiesterase 8A, [Score=589, Expect=0.0]; ENSG00000113231, PDE8B, phosphodiesterase 8B, [Score=568, Expect=0.0]; ENSG00000284762, AC022414.1, phosphodiesterase 8B, [Score=565, Expect=0.0]} {Mouse: ENSMUSG00000025584, Pde8a, phosphodiesterase 8A, [Score=579, Expect=0.0]; ENSMUSG00000021684, Pde8b, phosphodiesterase 8B, [Score=569, Expect=0.0]} {Dmel: FBgn0266377, Pde8, Phosphodiesterase 8, [Score=357, Expect=4e-110]} {Celegans: WBGene00022389, pde-6, Probable 3',5'-cyclic phosphodiesterase pde-6, [RH, Score=312, Expect=6e-94]} {Smed: dd_Smed_v6_10593_0_1, dd_Smed_v6_10593_0_1, [Score=410, Expect=2e-130]} {RNA1509_38664} {RNA1310_9544} {RNA815_9009} Mlig455_064265 {REF} {Length: 3769} {TRANSSPLICED} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=279.8]} {Human: ENSG00000073417, PDE8A, phosphodiesterase 8A, [Score=519, Expect=2e-172]; ENSG00000113231, PDE8B, phosphodiesterase 8B, [Score=495, Expect=4e-162]} {Mouse: ENSMUSG00000025584, Pde8a, phosphodiesterase 8A, [Score=499, Expect=1e-164]; ENSMUSG00000021684, Pde8b, phosphodiesterase 8B, [Score=496, Expect=8e-164]} {Dmel: FBgn0266377, Pde8, Phosphodiesterase 8, [Score=361, Expect=5e-112]} {Celegans: WBGene00022389, pde-6, Probable 3',5'-cyclic phosphodiesterase pde-6, [RH, Score=313, Expect=2e-94]} {Smed: dd_Smed_v6_10593_0_2, dd_Smed_v6_10593_0_2, [Score=404, Expect=1e-128]} {RNA1509_38664} {RNA1310_9544} {RNA815_9009} |
96. | MligTC455_30634 | 114 | 2.38 | Mlig455_025888 | Neo: - Age: Up-Down-Up Region-enriched R2: 6.750/0.00140 |
1.89 | - | - | - | 0.906 | 0.984 | - | Mlig455_025888 {REF} {Length: 5266} {Pfam: Integrase core domain [PF00665.28, score=50.8]; DDE superfamily endonuclease [PF13358.8, score=22.0]} {Smed: dd_Smed_v6_1574_6_72, dd_Smed_v6_1574_6_72, [Score=149, Expect=3e-41]} {RNA1509_47056} {RNA1310_5710.1} {RNA815_6291.1} | |
97. | MligTC455_15353 | 85 | 1.78 | Mlig455_015663, Mlig455_062473 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.265 Region-enriched R2: 9.386/0.02025 |
ARRB1 | 1.889 | - | - | - | 0.893 | 0.996 | - | Mlig455_015663 {REF} {Length: 1700} {Pfam: Arrestin (or S-antigen), N-terminal domain [PF00339.31, score=68.5]; Arrestin (or S-antigen), C-terminal domain [PF02752.24, score=52.0]} {Human: ENSG00000137486, ARRB1, arrestin beta 1, [Score=261, Expect=1e-83]; ENSG00000141480, ARRB2, arrestin beta 2, [Score=260, Expect=5e-83]} {Mouse: ENSMUSG00000018909, Arrb1, arrestin, beta 1, [Score=259, Expect=1e-82]; ENSMUSG00000060890, Arr3, arrestin 3, retinal, [Score=253, Expect=9e-81]; ENSMUSG00000060216, Arrb2, arrestin, beta 2, [Score=252, Expect=6e-80]} {Dmel: FBgn0040206, krz, kurtz, [Score=256, Expect=3e-81]} {Celegans: WBGene00000195, arr-1, Probable beta-arrestin, [Score=235, Expect=2e-73]} {Smed: dd_Smed_v6_5512_0_2, dd_Smed_v6_5512_0_2, [Score=321, Expect=4e-106]} {RNA1509_59210} {RNA1310_21679, RNA1509_59210} {RNA1509_59210, RNA815_10578.1} Mlig455_062473 {REF} {Length: 1703} {Pfam: Arrestin (or S-antigen), N-terminal domain [PF00339.31, score=71.8]; Arrestin (or S-antigen), C-terminal domain [PF02752.24, score=57.4]} {Human: ENSG00000137486, ARRB1, arrestin beta 1, [Score=268, Expect=5e-86]; ENSG00000141480, ARRB2, arrestin beta 2, [Score=268, Expect=4e-86]} {Mouse: ENSMUSG00000018909, Arrb1, arrestin, beta 1, [Score=265, Expect=5e-85]; ENSMUSG00000060216, Arrb2, arrestin, beta 2, [Score=260, Expect=5e-83]} {Dmel: FBgn0040206, krz, kurtz, [Score=259, Expect=3e-82]} {Celegans: WBGene00000195, arr-1, Probable beta-arrestin, [Score=239, Expect=8e-75]} {Smed: dd_Smed_v6_5512_0_2, dd_Smed_v6_5512_0_2, [Score=328, Expect=3e-109]} {RNA1509_59210} {RNA1310_21679} {RNA815_10578.1} |
98. | MligTC455_11110 | 100 | 2.08 | Mlig455_047439 | Neo: - Age: Down-Up-Up Region-enriched R2: 4.339/0.01851 |
1.888 | - | - | - | 0.891 | 0.997 | - | Mlig455_047439 {REF} {Length: 1641} {RNA1310_49834.1} {RNA815_39415} | |
99. | MligTC455_16974 | 15 | 0.32 | Mlig455_052824 | Neo: - Age: - |
1.888 | - | - | - | 0.904 | 0.984 | - | Mlig455_052824 {REF} {Length: 306} {NoTransDecoderORF} {RNA1310_65069} {RNA815_35708.2} | |
100. | MligTC455_34810 | 109 | 2.27 | Mlig455_024348, Mlig455_024465 | Neo: - Age: - Region-enriched R2: 5.365/0.04615 |
1.885 | - | - | - | 0.908 | 0.977 | - | Mlig455_024348 {REF} {Length: 934} {RNA1310_67817} {RNA815_52313} Mlig455_024465 {REF} {Length: 1036} {RNA1310_67817} {RNA815_52313} |